Using distinct kidney tumor cell lines, recently published data convincingly show enhanced binding of Gal3ST1-expressing renal cancer cells to platelets that resulted in protection of neoplastic cells against natural killer cell-triggered cytotoxic response, thus suggesting the tumor immune escape and worse prognosis35. The gene discussed is GAL3ST1; the disease is renal carcinoma.